These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 26025112)
1. Letter regarding Xiao WZ et al. entitled "Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis". Dai W; Chen J; Guo X; Su Z Tumour Biol; 2015 Jun; 36(6):4089. PubMed ID: 26025112 [TBL] [Abstract][Full Text] [Related]
2. Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis. Xiao WZ; Han DH; Wang F; Wang YQ; Zhu YH; Wu YF; Liu NT; Sun JY Tumour Biol; 2014 Jul; 35(7):6687-93. PubMed ID: 24705863 [TBL] [Abstract][Full Text] [Related]
3. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate. Yang Y; Shao N; Luo G; Li L; Zheng L; Nilsson-Ehle P; Xu N Anticancer Res; 2010 Mar; 30(3):981-5. PubMed ID: 20393024 [TBL] [Abstract][Full Text] [Related]
4. Exosomal PTEN as a Predictive Marker of Aggressive Gliomas. Patnam S; Samal R; Koyyada R; Joshi P; Singh AD; Nagalla B; Soma MR; Sannareddy RR; Ippili K; Raju S; Boola RG; Lath R; Ranjan A; Ghosh S; Balamurugan M; Ray A; Manda SV Neurol India; 2022; 70(1):215-222. PubMed ID: 35263886 [TBL] [Abstract][Full Text] [Related]
5. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma. Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871 [TBL] [Abstract][Full Text] [Related]
6. Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia. Abdullah JM; Farizan A; Asmarina K; Zainuddin N; Ghazali MM; Jaafar H; Isa MN; Naing NN Asian J Surg; 2006 Oct; 29(4):274-82. PubMed ID: 17098662 [TBL] [Abstract][Full Text] [Related]
7. The role of the PTEN gene in malignant gliomas. Alexiou GA; Voulgaris S Neurol Neurochir Pol; 2010; 44(1):80-6. PubMed ID: 20358487 [TBL] [Abstract][Full Text] [Related]
8. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients. Zainuddin N; Jaafar H; Isa MN; Abdullah JM Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579 [TBL] [Abstract][Full Text] [Related]
9. Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients. Zainuddin N; Jaafar H; Isa MN; Abdullah JM Southeast Asian J Trop Med Public Health; 2005 May; 36(3):748-56. PubMed ID: 16124450 [TBL] [Abstract][Full Text] [Related]
10. PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis. Han F; Hu R; Yang H; Liu J; Sui J; Xiang X; Wang F; Chu L; Song S Onco Targets Ther; 2016; 9():3485-92. PubMed ID: 27366085 [TBL] [Abstract][Full Text] [Related]
11. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL; J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268 [TBL] [Abstract][Full Text] [Related]
12. Relationship between PTEN gene expression and differentiation of human glioma. Yang Y; Shao N; Luo G; Li L; Nilsson-Ehle P; Xu N Scand J Clin Lab Invest; 2006; 66(6):469-75. PubMed ID: 17000554 [TBL] [Abstract][Full Text] [Related]
13. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells. Li J; An G; Zhang M; Ma Q Biochem Biophys Res Commun; 2016 Sep; 477(4):743-748. PubMed ID: 27363339 [TBL] [Abstract][Full Text] [Related]
15. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer. Qiu ZX; Zhao S; Li L; Li WM Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225 [TBL] [Abstract][Full Text] [Related]
16. Mutation of PTEN in glioma stem/progenitor cells: a case report. Zhao Y; Huang Q; Wang A; Dong J; Lan Q Cancer Genet Cytogenet; 2009 Dec; 195(2):183-5. PubMed ID: 19963122 [No Abstract] [Full Text] [Related]
17. PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis. Gu J; Ou W; Huang L; Wu J; Li S; Xu J; Feng J; Liu B; Zhou Y Minerva Med; 2016 Oct; 107(5):342-51. PubMed ID: 27333149 [TBL] [Abstract][Full Text] [Related]
18. Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples. Stankovic T; Milinkovic V; Bankovic J; Dinic J; Tanic N; Dramicanin T; Tanic N Biomed Pharmacother; 2014 Jun; 68(5):521-6. PubMed ID: 24767865 [TBL] [Abstract][Full Text] [Related]
19. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis. Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019 [TBL] [Abstract][Full Text] [Related]